JTO and OE contributed equally to the study hrangel2006@gmail.com Flavonoids are present in practically all plants and many biological activities have been described for them. The flavonoid quercetin is a common molecule for which anti-HIV activity has been demonstrated. Avicularin and guajaverin are derivatives of quercetin with a glycoside substituent in their structure. In this work, a mixture of both derivatives was purified from an extract of Psidium guinense. The mixture exhibited activity against HIV-1 in vitro, with an IC 50 of approximately 8.5 µg/mL, which compares favorably with the IC 50 of 53 µg/mL of quercetin. The mixture also inhibited HIV-1 reverse transcriptase (RT), with an IC 50 of 7.2 µM, compared to 0.6 µM for quercetin. These results are in agreement with the in silico prediction for the interaction of these flavonoids with RT and suggest that the glycosylic moiety could favor the transport of the compound into the cell. However, the glycosidic moiety might be cleaved intracellularly, being the resultant quercetin responsible for the antiviral activity.
Human Immunodeficiency Virus (HIV) is the viral infection against which most drugs are available for treatment. However, drug resistance and side effects have led to a need for new agents, medicinal plants, could be a valuable source for new antiviral agents [1] . The total saponin fraction of Psidium guajava has previously been described as containing inhibitors of HIV-1 fusion in vitro [2] but there are few studies characterizing compounds from Psidium guineense [3] . Psidium guineense Sw. is one of the 13 officially recorded species of the genus Psidium (Myrtaceae) in Venezuela [4] . Known as "guava", "guava savanna", "guayabito of hill" or "bush guayabito", it is very often collected and also hybridized with the common guava (Psidium guajava L.). It is a shrub with leathery leaves and yellowish-green ovate fruit. It grows almost everywhere in Venezuela, in warm and disturbed areas, savannas and gallery forests between 50 and 800 m. Its distribution extends from Mexico and the Caribbean to Bolivia, Paraguay and Northeastern Argentina [5, 6] .
Guava plants have been reported to contain phytochemicals active against some viruses, included HIV-1 [2, 7] . The leaves of guava are rich in flavonoids, particularly quercetin as the main active substance, as well as saponins, among others [8] . In many Pacific islands guava leaves are used to prepare an infusion or tea to treat diarrhea. The spasmolytic and antidiarrheal effects are associated with its quercetin-derived flavonoids and glycosides [9] . Based on the previously reported anti-HIV-1 activity of P. guajava compounds, the aim of this study was to evaluate the antiviral properties, of P. guineense (PG) against HIV-1 in vitro and to identify the bioactive compounds, different to saponin.
The cytotoxicity of the leaves extract of PG was evaluated in MT4 cells, before proceeding to further evaluation of its antiviral activity. The CC 50 for the crude extract was approximately 100 µg/mL. At 20 µg/mL the PG extract showed less than 20% cytotoxicity in MT4 cells (Figure 1) . Evaluation of the antiviral activity of PG revealed an IC 50 of 1.2 µg/mL (Figure 1) .
A bioassay-guided fractionation was performed with a Sephadex LH20 column chromatography (CC), and a mixture of methanol/water as eluent (1:1), yielding five major fractions (I to V). Fractions I to IV exhibited less than 20% antiviral activity and the main antiviral activity was concentrated in fraction V (Table 1) . Fraction V (PGVA) was purified by a low-pressure RP18 CC, with a mixture of methanol/water (3:7) to obtain a single peak that was initially perceived as pure since it showed only one spot on thinlayer chromatography sprayed with ceric sulfate [10] . (7) 2017 Ortega et al.
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Comparison of the
1 H-NMR and 13 C-NMR spectrums of PGVA with previous reports indicated that the fraction was composed of two quercetin derivatives, guajaverin (quercetin 3-Oarabinopyranoside) and avicularin (3-O-arabinofuranoside), being one or both responsible for the main antiviral activity present in the PG extract [11] . Table 1 : Antiviral activity and cytotoxicity of an isolated fraction of PG.
The % cytotoxicity and antiviral activity of two concentrations of the different fractions are shown, as median ± SEM.
Since PGVA was a mixture of quercetin derivatives, a comparative assay of PGVA and quercetin was carried out. Cytotoxicity was similar for quercetin and PGVA, but a marked difference was observed in the antiviral activity. The IC 50 for PGVA was 8.5 µg/mL while that of quercetin was 53 µg/mL, more than 6 times higher ( Figure 2 ).
The inhibitory effect (RT-IC 50 ) of quercetin and guajaverin/avicularin on HIV-1 reverse transcriptase was evaluated using a fluorometric assay ( Figure 3 ) and found to be 0.7 µM and 7.2 µM respectively. The RT-IC 50 for the mixture of guajaverin/avicularin was higher than that of nevirapine (1.4 µM), used as the positive control, and 10 times higher than that of quercetin. In silico prediction of the interaction and possible RT inhibition resulted in a similar behavior with a better fit compound/target for quercetin, with a Ki= 2.7 µM and a binding energy (bE) of -7.2 Kcal/mol, compared to guajaverin and avicularin with Ki=84.9 µM, bE= -6.6 Kcal/mol and Ki=879 µM, bE=-5.1 Kcal/mol respectively.
In the present study, we identified two isomeric glycosylated flavonoids, guajavarin and avicularin, that are derivatives of quercetin and exhibit anti-HIV activity. Previous studies have described the antiviral, antibacterial, antifungal and antiinflammatory properties of plants that belong to the Psidium genus [7, 12, 13] . Mao et al., in 2010 [2] described the anti-HIV-1 activity of saponins present in an aqueous extract of Psidium guajava. Interestingly, to the best of our knowledge, this is the first report of derivates of quercetin associated with the anti-HIV-1 activity. As other glycosylated flavonoids, guajaverin and avicularin exist in a keto-enol tautomeric equilibrium [14] . This reaction is spontaneous and tends to equilibrium so for this reason the mixture was evaluated as a single compound. These flavonoids have also been isolated from others members of the Psidium genus. The glycosyl moiety in the structure of quercetin may play a role in the activity of these compounds. Previous reports suggest that quercetin glycosylates are substrates for enzymes that function as carbohydrate transporters in the cell membrane, i.e. the sodiumdependent glucose transporter SGLT1 [15] and the bilitranslocase have been shown to be involved in the transport of different flavonoids [16] . Thus it is conceivable that the addition of the sugar moiety on the quercetin molecule may improve the solubility and transport into the cell and thus the active intracellular concentration. Nahir et al., in 2009 [17] described that quercetin has antiviral activity in an in vitro model of HIV-1. These authors suggested that the probable inhibitory mechanisms may be related to the downregulation of HIV-1 entry co-receptors and modulation of pro-antiinflammatory cytokine expression. On the other hand, Pasetto et al., in 2014 [18] , described the anti-HIV-1 activity of myricetin, quercetin and pinocembrin, finding that these flavonoids were active against HIV-1. They proposed that these compounds may modulate important steps in the HIV-1 life cycle, such as entry, reverse transcriptase, integration and maturation. These researchers evaluated the inhibitory activity of myricetin on HIV-1 reverse transcriptase and found that myricetin can inhibit HIV-1 RT (IC 50 203 mM). Comparatively the mixture of guajaverin/avicularin show a higher inhibition than quercetin on the HIV-1 replication. However, when the effect was evaluated on the HIV-1 RT in vitro and in silico, quercetin exhibited a higher anti-HIV-1 RT activity. Based on this observation and the information available on the transport of glycosylated derivatives of quercetin [15] , we suggest that an augment in the uptake of the quercetin derivatives increase the availability of the compound inside the cell. The sugar moiety might then be cleaved, leaving quercetin to mediate the antiviral activity. This possible hypothesis would explain the results obtained in this work, although more studies are required to verify this hypothesis. 
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A total of 200 g of fresh leaves of P. guineense (PG) were boiled in water for 5 minutes, cooled to room temperature and filtered to remove solids. The filtered product was lyophilized, yielding 4.25 g of dried extract. The fractionation and identification of the compound in the extract was done with RediSep® Rf Reversedphase C18 was used for low pressure CC, and silica gel 60 RP18 F254 (E. Merck) for TLC on glass (Merck). Sephadex® LH-20 (Sigma) was employed for gel permeation chromatography. 1 H-and 13 C-NMR spectra were obtained using a Bruker DRX 300 (300 MHz for 1 H and 75 MHz for 13 C) in DMSO-d6. All solvents used were of commercial HPLC grade. MT4 cells were seeded in 96 wells/plate at a density of 30,000 cells/well, to which different concentrations of compounds were added. After 24 h., the cultures were evaluated with MTT cell proliferation assay (Sigma-USA) to determine the percentage of dead cells.
MT4 cells at a density of 30,000 cells/well were infected with HIV-1 at a multiplicity of infection of 0.03. The extract or the purified compounds/fractions were evaluated at different concentrations. Virus production was evaluated after 72h. Viral growth was determined by detecting the viral antigen p24 using an in-house ELISA [21] . The results were expressed relative to untreated HIV-1-infected cells. Statistical analysis (Student´s t-Test) of results of at least three independent experiments was performed using Prism GraphPad 6 version 6.01 (p ≤ 0.05 used as level of significance).
Reverse transcriptase assay:
The inhibitory activity of compounds against HIV-1 reverse transcriptase was evaluated using the EnzChek Reverse Transcriptase Assay kit (Molecular Probes, Inc., USA). A purified reverse transcriptase enzyme purchased from Worthington Biochemical Corporation and Nevirapine were used as controls of enzyme and antiviral drug respectively. All results were normalized to the respective control (reaction buffer) and the basal fluorescence of each compound.
A crystal structure of HIV-1 reverse transcriptase, suitable as a docking target was obtained from a protein databank [22] . Inclusion criteria used to choose the target were: wild type HIV-1-RT, binding with ligand or inhibitor, complete chain information and resolution less than 3.0 Å. The chosen protein structure was 3v81, a crystal structure of HIV-1 reverse transcriptase (RT) bound with DNA and the non-nucleoside inhibitor nevirapine [23] . The structure was optimized using VegaZZ 3.1.0.21. Atomic charges and the atom potentials were assigned (CHARMM/Gasteiger), and then NAMD minimization developed. Structures were downloaded from thePuchem database and AutoDock4 was developed with the VegaZZ platform.
